Smiths Industries Appoints New Executive Director
Lawrence Kinet to Take The Helm
LONDON-Lawrence Kinet has been appointed executive director of Smiths Industries plc and will replace George M. Kennedy CBE as head of Smiths Industries Medical Systems when Kennedy retires on August 4, 2000. Kinet earned his BSc at the University of Birmingham, UK, in 1968 and his MBA from the University of Chicago in 1970. From 1973-1988, Kinet held various positions at Baxter International Inc. concluding his career there as Corporate VP & President, World Trade Group. Subsequently he joined The Kensington Group as Managing Partner from 1989-1991 and from 1991-1994 he was the Chairman & CEO of Oculon Corporation. Most recently, Kinet held the position of Chairman, President & CEO of Aksys Ltd from 1994-1999. A US citizen, Kinet will relocate to Smiths Industries headquarters in London.
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.
